Theravance Biopharma, Inc. (TBPH)
17.03
0.00 (0.00%)
USD |
NASDAQ |
Sep 24, 16:00
Theravance Biopharma Gross Profit (Annual) : 101.95M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 101.95M |
| December 31, 2024 | 58.37M |
| December 31, 2023 | 51.37M |
| December 31, 2022 | 44.76M |
| December 31, 2021 | 48.02M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 56.49M |
| Date | Value |
|---|---|
| December 31, 2017 | 9.356M |
| December 31, 2016 | 44.19M |
| December 31, 2015 | 37.47M |
| December 31, 2014 | 7.63M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 11.01M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Zymeworks, Inc. | 95.17M |
| Viatris, Inc. | 5.648B |
| Ocular Therapeutix, Inc. | 45.38M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |